Tag: CARTITUDE4

Legend Biotech to Unveil Minimal Residual Illness Information from Landmark CARTITUDE-4 Trial in A number of Myeloma By Investing.com

New knowledge will showcase considerably elevated and sustained minimal residual illness (MRD) negativity charges, reinforcing the potential of CARVYKTI to…

Business